Latin America in Vitro Diagnostics (IVD) Market 2024 The latin america IVD market is expected to 2024 | Page 2

In 2015, Brazil was the largest regional segment with a revenue generation of over USD 1.2 billion owing
to the established healthcare infrastructure, growing awareness for cancer screening, and the increasing
demand for genetic testing.
Peru is expected to be one of the fastest growing regions on account of the growing economic stability,
high unmet clinical needs, and the rising disposable incomes
Key players operating in the Latin America IVD market are Roche Diagnostics, Abbott Laboratories, Inc.,
Hologic (Gen-Probe), Becton Dickinson (BD) Company, Alere, Inc., Bio-Rad Laboratories, Qiagen N.V.,
Inc., bioMerieux, BioQuidel Corporation, and Siemens Healthcare.

Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Read Complete Report With TOC @ http://www.radiantinsights.com/research/latin-america-invitro-diagnostics-ivd-market
Chapter 2. Executive Summary
2.1. Latin America IVD Market- Industry Snapshot and Key Buying Criteria, 2015

Chapter 3. Latin America IVD Industry Outlook
3.1. Latin America IVD Market Segmentation
3.2. Latin America IVD Market Size and Growth Outlook
3.3. Latin America IVD Market Dynamics
3.3.1. Market Drivers Estimates
3.3.1.1. Substantial Increase in Geriatric Population in Latin America
3.3.1.2. Considerable Prevalence of Chronic Disease
3.3.1.3. Growing Need for Point of Care Facilities.
3.3.2. Market Restraint Estimates